课题基金 / 基金详情

Establishment of an animal model for mammary cancer metastasis, and the search for anti-metastatic substances

Establishment of an animal model for mammary cancer metastasis, and the search for anti-metastatic substances
乳腺癌转移动物模型的建立及抗转移物质的寻找
批准号:
07680924
负责人:
MORIMOTO Junji
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

MORIMOTO Junji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have been studying cancer metastasis (animal model for cancer metastasis and anti-metastatic substances), and obtained following results with support by the grant-in-aid for scientific research.1. Using mouse and human breast cancer cell lines, we compared the susceptibility to metastasis among the immunodeficient mouse strains BALB/c-nude, Lasat and SCID, and found SCID mice to have advantages over BALB/c-nude and Lasat mice. in frequency of incidence of metastasis and condition of metastatic colonies.2. We newly established a high mammary cancer strain of mice with severe pulmonary metastasis by infecting BALB/c mice with JygMMTV.With repeated sib-mating, we have reached the F9 to F10 generations at present. At the F6 generation, the incidence of cancer is 91%, the average age of incidence is 11.2 months. and the metastatic rate is 72% (microscopically).3. With repeated subcutaneous transplantation of lung metastatic tissues, we produced an animal model for cancer metastasis. In this model, we can visually observe almost 100% lung metastasis within 2-3 months after, transplantation. We are also currently trying to establish a lymphatic metastasis model using the same method.4. We established a new munne mammary cancer cell line (BJMC338) from the mammary tumor of a JygMMTV infected BALB/c mouse, with metastatic colonies in the lung and liver.This cell line is useful as an experimental metastatic model with an i.v. of cells, and not so with s.c., spontaneous metastatic research.5. Next we searched for substances with anti-cancer and metastatic activities in marine biomatenals, especially sea weeds. Using the mouse melanoma cell (B16-BL6) and mammary cancer cell (BJMC338) model we established, we found that Marginisporum crassissium, and Laminaria anguestata inhibit cancer metastasis in the melanoma model, and Laniinaria anguestata does so in the inanurlary cancer model.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Yogendra SINGH 他: "マウス乳癌自然転移株(JYG-B)における血管新生阻害剤(TNP-470)の腫瘍増殖ならびに転移抑制効果" 乳癌基礎研究. 5. 57-60 (1996)
Yogendra SINGH 等人:“血管生成抑制剂 (TNP-470) 在自发性转移性小鼠乳腺癌品系 (JYG-B) 中的肿瘤生长和转移抑制作用”乳腺癌基础研究。 5. 57-60 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
森本,純司他: "種々免疫不全マウスにおける乳癌転移能の比較" 乳癌基礎研究. 5. 52-56 (1996)
Morimoto, Junji 等人:“不同免疫缺陷小鼠乳腺癌转移潜力的比较”乳腺癌基础研究 5. 52-56 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yogendra singh et.al.: "Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer Cell lines in vitro and in vivo" Breast Cancer Research and treatment. (in press). (1997)
Yogendra singh 等人:“血管生成抑制剂 TNP-470 对乳腺癌细胞系的体外和体内抑制肿瘤生长和转移”乳腺癌研究和治疗。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shingh Y.et al.: "Inhibitory Effect of the Angiogenesis lnhibitor O-(Chloroacetyl-carbamoyl)fumagillol(TNP-470)on Tumor Growth and Metastasis of Murine Mammary Tumor Cell Line(JYG-B)I noculatedin female Nude Mice" Breast Cancer. vol.3 No.2. 105-110 (1996)
Shingh Y.等人:“血管生成抑制剂 O-(氯乙酰基-氨基甲酰基)烟曲霉醇 (TNP-470) 对雌性裸鼠乳房中接种的小鼠乳腺肿瘤细胞系 (JYG-B)I 肿瘤生长和转移的抑制作用”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Formation and Properties of Selecting Functionally Gradient Sprayed Coating by Direct Diode Laser/ Cold Spray Process
    • 批准号:
      17560644
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Junji
    • 依托单位:
    Improvement of Metal/Ceramic Composite Sprayed Coatiog by Electrolytic Arc Heating Method and Evaluation of the Coating Properties
    • 批准号:
      12650724
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      2000
    • 负责人:
      MORIMOTO Junji
    • 依托单位:
    海外基金